Table: Rohto -Q1 group results

Rohto Pharmaceutical

09/08/2023 07:00

Aug 9 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               61.17               52.26           263.00    
                   (+17.1 pct)         (+23.5 pct)      (+10.2 pct) 
  Operating           11.29                8.30            37.00    
                   (+36.1 pct)         (+37.7 pct)      (+9.0 pct)  
  Recurring           12.24                9.65            38.00    
                   (+26.9 pct)         (+47.6 pct)      (+6.8 pct)  
  Net                  9.09                6.99            27.50    
                   (+30.0 pct)         (+47.2 pct)      (+4.3 pct)  
  EPS               39.85 yen           30.65 yen       120.54 yen  
  EPS Diluted       39.73 yen           30.56 yen                   
  Ann Div                                                24.00 yen  
  -Q2 div                               20.00 yen        12.00 yen  
  -Q4 div                               12.00 yen        12.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T